G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Vice President - Head of Audit & Risk Management

Internal Audit & ControlsConfirmed live in the last 24 hours
Full-timeFoster City, CA, USANo salary listed

About the Job

Requirements

  • The candidate should have 15 or more years of progressive experience across Internal Audit, enterprise risk management, public accounting, finance, controls, or related disciplines within complex, global organizations.
  • The candidate should have significant experience leading a global internal audit function for a publicly traded multinational company.
  • The candidate should have broad expertise across risk-based internal audit, enterprise risk management, governance, internal controls, Sarbanes-Oxley (SOX), compliance, operational risk, and technology risk.
  • The candidate should have experience owning or meaningfully leading enterprise risk management and risk governance, including identifying and assessing emerging risks and communicating the enterprise risk profile to senior leadership and the Board.
  • The candidate should have demonstrated success modernizing Internal Audit and risk management through technology, advanced analytics, automation, continuous auditing, and artificial intelligence-enabled capabilities.
  • The candidate should have experience navigating complex, highly regulated operating environments.
  • The candidate should have experience assessing risks across commercial activities, technology and cybersecurity, supply chain, manufacturing, and other enterprise processes.
  • The candidate should have a strong understanding of professional Internal Audit standards and public-company governance and control requirements.
  • The candidate should be able to lead, develop, and mentor high-performing teams while building organizational capability and developing future leaders.
  • The candidate should have significant experience interacting with Audit Committees and Boards of Directors, and the executive presence, judgment, and communication skills to engage credibly with the Chief Executive Officer and other senior executives.
  • A bachelor's degree in Accounting, Finance, Business, or a related discipline is required.
  • The candidate should model inclusive leadership and embed diversity, equity, and inclusion in team operations, decision-making, and talent development.
  • The candidate should understand employees’ skills, aspirations, and potential, and provide coaching, feedback, and opportunities that develop current performance and future readiness.
  • The candidate should align team goals with enterprise and R&D priorities, clarify decision rights, remove barriers, and connect the team to the broader Public Affairs and R&D ecosystem.

Responsibilities

  • Develop and execute a comprehensive, risk-based Internal Audit strategy aligned with Gilead’s strategic priorities, operating environment, and evolving enterprise risk profile.
  • Lead annual audit planning and risk assessment, adjusting audit priorities as business conditions and emerging risks evolve.
  • Provide independent assurance across financial, operational, commercial, compliance, and technology-related risks and controls, including cybersecurity, data, supply chain, and manufacturing.
  • Evaluate governance, risk management, internal controls, and key business processes, and provide actionable recommendations that strengthen the organization while enabling the business.
  • Oversee audit execution and quality across global operations and affiliates, and ensure significant findings and remediation plans are tracked and communicated.
  • Coordinate with external auditors and other assurance and compliance functions to ensure effective enterprise risk coverage and minimize unnecessary duplication.
  • Lead the enterprise risk management framework and related governance processes, maintaining a comprehensive, forward-looking view of principal and emerging risks, including cybersecurity, artificial intelligence, and other rapidly evolving risks.
  • Facilitate organization-wide risk identification and assessment, partnering with senior leaders and risk owners to evaluate exposure, mitigation strategies, and changes in the business and external environment.
  • Provide senior management and the Audit Committee with an integrated view of enterprise risk, identifying themes, interdependencies, and emerging issues requiring leadership attention.
  • Evolve risk management toward dynamic and continuous monitoring, using data and technology to identify changes in risk indicators earlier.
  • Set the vision and roadmap for modernizing Internal Audit and risk management, building on the existing foundation and identifying opportunities to adopt leading practices.
  • Accelerate the use of technology, data analytics, automation, and artificial intelligence across the audit lifecycle, including risk assessment, planning, testing, monitoring, and reporting.
  • Partner with technology, cybersecurity, and business leaders as Gilead expands its use of artificial intelligence and other emerging technologies, incorporating related risks, governance, and controls into audit and enterprise risk frameworks.
  • Lead development, implementation, and maintenance of the Business Continuity Management framework, policies, and resilience strategies.
  • Lead organization-wide Business Impact Analyses to identify critical business processes, operational dependencies, and recovery time and recovery point objectives.
  • Oversee creation and regular updating of Business Continuity Plans and technical Disaster Recovery strategies in partnership with IT and department heads.
  • Design and facilitate tabletop exercises, functional drills, and full-scale disaster simulations to validate readiness and identify gaps.
  • Advise the Audit Committee on Internal Audit and enterprise risk management, providing independent perspectives on significant risks, audit findings, control matters, and remediation progress.
  • Maintain effective communication with the Audit Committee and ensure the function has the independence, access, and authority necessary to fulfill its responsibilities.
  • Build trusted relationships with the Chief Executive Officer, Chief Financial Officer, and senior leadership team, raising significant and emerging issues early and translating complex risk matters into decision-relevant insights.
  • Provide regular enterprise-risk updates to senior leadership and facilitate discussion of emerging risks and mitigation priorities.
  • Balance independence and professional skepticism with a collaborative, pragmatic approach to serving as a valued partner to the business.
  • Lead, develop, and mentor the global Audit & Risk Management organization, fostering integrity, intellectual curiosity, accountability, collaboration, and continuous improvement.
  • Develop a high-performing audit and risk function using audit, risk, technology, analytics, and business expertise to support evolving organizational needs.
  • Develop emerging leaders, strengthen succession planning, and create opportunities for team members to broaden their experience and impact.
  • Build a technology-forward mindset across the team and develop the skills needed for a data-driven, artificial intelligence-enabled audit and risk environment.
  • Set clear priorities and performance expectations while allocating resources flexibly to Gilead’s significant and rapidly evolving risks.

Desired Qualifications

  • Pharmaceutical or life sciences experience is valued but not required.
  • A Certified Public Accountant (CPA), Certified Internal Auditor (CIA), Certified Information Systems Auditor (CISA), and/or an advanced degree is preferred.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs